Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Current Heart Failure Reports
Erschienen in: Current Heart Failure Reports 6/2016

22.11.2016 | Pathophysiology of Myocardial Failure (I Anand and M Patarroyo-Aponte, Section Editors)

New Challenges in the Treatment of Patients With Left Ventricular Support: LVAD Thrombosis

verfasst von: Ann B. Nguyen, Nir Uriel, Sirtaz Adatya

Erschienen in: Current Heart Failure Reports | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Mechanical circulatory support has revolutionized the treatment of heart failure, affording patients significantly improved survival and quality of life. However, further advancements in this technology have been hindered by adverse events, particularly gastrointestinal bleeding, driveline infection, stroke, and device thrombosis. Recently, there has been a renewed focus on device thrombosis as the reported incidence has increased. This review focuses on an update on the diagnostic modalities and current treatment algorithms of this serious complication.
Literatur
1.
Kirklin JK, Naftel DC, Kormos RL, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2014;33:12–22.CrossRefPubMed
2.
Netuka I, Sood P, Pya Y, et al. Fully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter study. J Am Coll Cardiol. 2015;66:2579–89.CrossRefPubMed
3.
Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125:3191–200.CrossRefPubMed
4.
Starling RC, Moazami N, Silvestry SC, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med. 2014;370:33–40.CrossRefPubMed
5.
Najjar SS, Slaughter MS, Pagani FD, et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2014;33:23–34.CrossRefPubMed
6.
Stulak JM, Dunlay SM, Sharma S, et al. Treatment of device thrombus in the HeartWare HVAD: success and outcomes depend significantly on the initial treatment strategy. J Heart Lung Transplant. 2015;34:1535–41.CrossRefPubMed
7.
Scandroglio AM, Kaufmann F, Pieri M, et al. Diagnosis and treatment algorithm for blood flow obstructions in patients with left ventricular assist device. J Am Coll Cardiol. 2016;67:2758–68.CrossRefPubMed
8.
9.
Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol. 2008;143:180–90.CrossRefPubMed
10.
Wu ZJ, Antaki JF, Burgreen GW, Butler KC, Thomas DC, Griffith BP. Fluid dynamic characterization of operating conditions for continuous flow blood pumps. ASAIO J. 1999;45:442–9.CrossRefPubMed
11.
Sin DC, Kei HL, Miao X. Surface coatings for ventricular assist devices. Expert Rev Med Devices. 2009;6:51–60.CrossRefPubMed
12.
Goldstein DJ, John R, Salerno C, et al. Algorithm for the diagnosis and management of suspected pump thrombus. J Heart Lung Transplant. 2013;32:667–70.CrossRefPubMed
13.
Boyle AJ, Jorde UP, Sun B, et al. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. J Am Coll Cardiol. 2014;63:880–8.CrossRefPubMed
14.
Koene RJ, Win S, Naksuk N, et al. HAS-BLED and CHA2DS2-VASc scores as predictors of bleeding and thrombotic risk after continuous-flow ventricular assist device implantation. J Card Fail. 2014;20:800–7.CrossRefPubMed
15.
Kirklin JK, Naftel DC, Pagani FD, et al. Pump thrombosis in the Thoratec HeartMate II device: an update analysis of the INTERMACS registry. J Heart Lung Transplant. 2015;34:1515–26.CrossRefPubMed
16.
Taghavi S, Ward C, Jayarajan SN, Gaughan J, Wilson LM, Mangi AA. Surgical technique influences HeartMate II left ventricular assist device thrombosis. Ann Thorac Surg. 2013;96:1259–65.CrossRefPubMed
17.
Teuteberg JJ, Slaughter MS, Rogers JG, et al. The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies. JACC Heart Fail. 2015;3:818–28.CrossRefPubMed
18.
Uriel N, Pak SW, Jorde UP, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56:1207–13.CrossRefPubMed
19.
Letsou GV, Connelly JH, Delgado RM, et al. Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency? J Heart Lung Transplant. 2006;25:395–9.CrossRefPubMed
20.
Emani S, Keebler M, Ransom J, et al. Prevention of HeartMate II pump thrombosis—recommendations and preliminary observations from the PREVENT study. Circulation. 2015;132:A16405.
21.
Cowger JA, Romano MA, Shah P, et al. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant. J Heart Lung Transplant. 2014;33:35–43.CrossRefPubMed
22.
Shah P, Mehta VM, Cowger JA, Aaronson KD, Pagani FD. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support. J Heart Lung Transplant. 2014;33:102–4.CrossRefPubMed
23.
Ravichandran AK, Parker J, Novak E, et al. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes. J Heart Lung Transplant. 2014;33:44–50.CrossRefPubMed
24.
Uriel N, Morrison KA, Garan AR, et al. Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study. J Am Coll Cardiol. 2012;60:1764–75.CrossRefPubMedPubMedCentral
25.
Uriel N, Han J, Morrison KA, et al. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. J Heart Lung Transplant. 2014;33:51–9.CrossRefPubMed
26.
Adatya S, Holley CT, Roy SS, et al. Echocardiographic ramp test for continuous-flow left ventricular assist devices: do loading conditions matter? JACC Heart Fail. 2015;3:291–9.CrossRefPubMed
27.
Adatya S, Adataya S, Masri C, John R, Eckman P. Loading conditions influence reliability of the echocardiographic ramp test in continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2013;32:1142–4.CrossRefPubMed
28.
Fine NM, Topilsky Y, Oh JK, et al. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis. JACC Cardiovasc Imaging. 2013;6:1129–40.CrossRefPubMed
29.
Kaufmann F, Hörmandinger C, Stepanenko A, et al. Acoustic spectral analysis for determining pump thrombosis in rotary blood pumps. ASAIO J. 2014;60:502–7.CrossRefPubMed
30.
Levin AP, Saeed O, Willey JZ et al. Watchful waiting in continuous-flow left ventricular assist device patients with ongoing hemolysis is associated with an increased risk for cerebrovascular accident or death. Circ Heart Fail. 2016;9:e002896.
31.
Hasin T, Deo S, Maleszewski JJ, et al. The role of medical management for acute intravascular hemolysis in patients supported on axial flow LVAD. ASAIO J. 2014;60:9–14.CrossRefPubMed
32.
Schlendorf K, Patel CB, Gehrig T, et al. Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices. J Card Fail. 2014;20:91–7.CrossRefPubMed
33.
Prasad SM, Robertson JO, Itoh A, Joseph SM, Silvestry SC. Histologic analysis of clots in explanted axial continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2015;34:616–8.CrossRefPubMed
34.
Levin AP, Uriel N, Takayama H, et al. Device exchange in HeartMate II recipients: long-term outcomes and risk of thrombosis recurrence. ASAIO J. 2015;61:144–9.CrossRefPubMed
35.
Soleimani B, Stephenson ER, Price LC, El-Banayosy A, Pae WE. Clinical experience with sternotomy versus subcostal approach for exchange of HeartMate II left ventricular assist device. Ann Thorac Surg. 2015;100:1577–80.CrossRefPubMed
36.
Jorde UP, Aaronson KD, Najjar SS, et al. Identification and management of pump thrombus in the HeartWare left ventricular assist device system: a novel approach using log file analysis. JACC Heart Fail. 2015;3:849–56.CrossRefPubMed
37.
Adatya S, Uriel N, Yarmohammadi H, et al. Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support. JACC Heart Fail. 2015;3:314–22.CrossRefPubMed
38.
Adatya S, John R, Eckman PM. Treatment of hemolysis with intravenous unfractionated heparin using an antifactor Xa-based monitoring protocol. J Thorac Cardiovasc Surg. 2015;149:1465–6.CrossRefPubMed
39.
Tellor BR, Smith JR, Prasad SM, Joseph SM, Silvestry SC. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices. J Heart Lung Transplant. 2014;33:94–101.CrossRefPubMed
40.
Adatya S, Bennett MK. Anticoagulation management in mechanical circulatory support. J Thorac Dis. 2015;7:2129–38.PubMedPubMedCentral
41.
Netuka I, Sood P, Pya Y, et al. Fully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter study. J Am Coll Cardiol. 2015;66:2579–89.CrossRefPubMed
42.
Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125:3191–200.CrossRefPubMed
Metadaten
Titel
New Challenges in the Treatment of Patients With Left Ventricular Support: LVAD Thrombosis
verfasst von
Ann B. Nguyen
Nir Uriel
Sirtaz Adatya
Publikationsdatum
22.11.2016
Verlag
Springer US
Erschienen in
Current Heart Failure Reports / Ausgabe 6/2016
Print ISSN: 1546-9530
Elektronische ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-016-0310-z

Weitere Artikel der Ausgabe 6/2016

Current Heart Failure Reports 6/2016 Zur Ausgabe

Pathophysiology of Myocardial Failure (I Anand and M Patarroyo-Aponte, Section Editors)

Heart Failure Secondary to Chagas Disease: an Emerging Problem in Non-endemic Areas

Comorbidities of Heart Failure (C Angermann, Section Editor)

Obstructive Ventilatory Disorder in Heart Failure—Caused by the Heart or the Lung?

Pathophysiology of Myocardial Failure (I Anand and M Patarroyo-Aponte, Section Editors)

Pulmonary Hypertension in Heart Failure Patients: Pathophysiology and Prognostic Implications

Comorbidities of Heart Failure (C Angermann, Section Editor)

Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications

Management of Heart Failure (T Meyer, Section Editor)

New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (S Katz, Section Editor)

Autonomic Modulation With Baroreflex Activation Therapy in Heart Failure

Neu im Fachgebiet Kardiologie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Prävention und Rehabilitation in der Kardiologie | Nachrichten

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

19.04.2024 | Vorhofflimmern | Nachrichten

Parodontalbehandlung verbessert Prognose bei Katheterablation

18.04.2024 | Arterielle Hypertonie | Nachrichten

Antihypertensiva schützen auch alte Menschen noch vor Demenz
weitere anzeigen

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen